TED Fellows chose Elizabeth Wayne, the first and only fellow in the T32 program at the UNC Eshelman School of Pharmacy, as one of 15 people from all over the world to present at the conference in Vancouver, Canada, this April.
Wayne will discuss her research in using immune cells as a drug delivery technique for curing cancer.
She said she always knew she wanted to be a TED Fellow and was excited and humbled when she found out in December she was chosen for the program.
“It’s huge, because for TED to choose me, it means they think I have an idea worth sharing,” she said. “I’ve always liked ideas and I believe in the power of ideas and I believe in the power of science communication.”
Wayne said through studying imaging, cancer and metastasis, she became interested in drug delivery and how immune cells already found in the body could might be used as a drug delivery technique for metastasized cancer.
“I like to say that who knew the best delivery vehicle we have wouldn’t be an Uber or a Lyft, but an immune cell,” Wayne said.
At the conference, she will explain how attaching drug particles to immune cells could be the most effective way to transport drugs through the body. This could potentially cure cancer and stop metastasis — the spread of cancer that causes most deaths from the disease.
“Immune cells are already able to go across the blood-brain barrier, which drugs have a hard time doing,” she said. “They can go through tumors, they are found in tumors — and so for me, this seemed like a pretty neat idea.”